Re-profiling of selected FDA approved drugs against C-jun N-terminal kinase (JNK) in ischemic stroke
Zikra Zulfiqar (21863)
Re-profiling of selected FDA approved drugs against C-jun N-terminal kinase (JNK) in ischemic stroke - Islamabad (unpublished) 2019 - x, 70 p. : ill., Col. ; 30 cm. +CD
A thesis is submitted in partial fulfillment of the requirements for the degree of Master of Philosophy to the Faculty of Pharmaceutical Sciences. Includes bibliographical references Thesis supervisor: Dr. Fawad Ali Shah Co-supervisor: Dr. Alam Zeb
Thesis (M.Phil.)--Riphah International University, 2019
English
Pharmacology--Bioinformatics resouces--Neurobehavioral testing--Antioxidant analysis--Brain infarction--Drugs--RIPS
615.1 / ZIK
Re-profiling of selected FDA approved drugs against C-jun N-terminal kinase (JNK) in ischemic stroke - Islamabad (unpublished) 2019 - x, 70 p. : ill., Col. ; 30 cm. +CD
A thesis is submitted in partial fulfillment of the requirements for the degree of Master of Philosophy to the Faculty of Pharmaceutical Sciences. Includes bibliographical references Thesis supervisor: Dr. Fawad Ali Shah Co-supervisor: Dr. Alam Zeb
Thesis (M.Phil.)--Riphah International University, 2019
English
Pharmacology--Bioinformatics resouces--Neurobehavioral testing--Antioxidant analysis--Brain infarction--Drugs--RIPS
615.1 / ZIK